Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases

 

    Related Conference of Hepatitis: Screening and Testing Methods

    August 27-28, 2025

    13th World Gastro Summit

    Paris, France
    May 21-22, 2026

    17th International Conference on Liver Diseases & Hepatology

    Aix-en-Provence, France
    June 18-19, 2026

    9th International Congress on Viral Hepatitis

    Paris, France
    June 29-30, 2026

    5th International Conference on Gastroenterology and Liver

    Aix-en-Provence, France
    August 03-04, 2026

    21st Euro-Global Gastroenterology Conference

    London, UK

    Hepatitis: Screening and Testing Methods Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in